Quick Answer
Fulgent Genetics, Inc. reported Stockholders Equity of $1.11 billion for fiscal year 2025.
Fulgent Genetics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.11B | -1.9% |
| 2024 | $1.13B | -0.3% |
| 2023 | $1.14B | -10.3% |
| 2022 | $1.27B | +9.3% |
| 2021 | $1.16B | +103.5% |
| 2020 | $569.39M | +587.9% |
| 2019 | $82.78M | +61.8% |
| 2018 | $51.15M | -5.6% |
| 2017 | $54.18M | -0.6% |
| 2016 | $54.48M | +958.7% |
| 2015 | $5.15M | +205.6% |
| 2014 | $1.68M | -14.4% |
| 2013 | $1.97M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.13B | -1.1% | +0.8% |
| June 30, 2025 | $1.12B | -1.4% | -0.9% |
| March 31, 2025 | $1.13B | -0.2% | -0.5% |
| December 31, 2024 | $1.13B | -0.3% | -0.5% |
| September 30, 2024 | $1.14B | -9.6% | +0.5% |
| June 30, 2024 | $1.13B | -10.1% | +0.2% |
| March 31, 2024 | $1.13B | -10.6% | -0.5% |
| December 31, 2023 | $1.14B | -10.3% | -9.7% |
- Fulgent Genetics, Inc. showed a decrease of -1.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2013–2025 period, Fulgent Genetics, Inc.’s stockholders equity has grown by 56432.2% (from $1.97 million to $1.11 billion).
- The most recent figure is from Fulgent Genetics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: